Mitochondrial VDAC1-based peptides: attacking oncogenic properties in glioblastoma
In a new study reported in The Lancet, Tirzepatide, a GLP-1R/GIPR agonist, reduced alcohol's rewarding properties, locomotor stimulation, conditioned place preference, and accumbal dopamine release
VCAM-1: vascular cell adhesion molecule 1
2 In a press release, Caremark president Ed DeVaney said the company is creating access and options that would not have existed without our leadership in the market, and that Caremark acted boldly through active engagement and negotiation with our drug manufacturer partners to tackle affordability and access for our customers and their members. 1 The company said it expects the formulary updates to drive increased savings in the weight management category, building on what it describes as a history of delivering double-digit savings for template formulary customers year over year
The researchers analyzed electronic health record data from more than 98 healthcare organizations, covering nearly two decades of treatment patterns